- Pancreatic cancer accounted for
3.2% , and prostate cancer accounted for 14.2% of all new cancer cases in 2022 in the United States. - Pancreatic cancer, in particular, can be difficult to treat and has a much higher mortality rate than many forms of cancer, what may be due to the fact it is often diagnosed late.
- Korean researchers recently devised a way to detect both pancreatic and prostate cancer with a urine test.
- With pancreatic cancer on the rise in younger women, this technology may provide a route to earlier cancer detection and treatment.
A team led by researchers from the Surface & Nano Materials Division of the Korea Institute of Materials Science recently published a study in Biosensors and Bioelectronics showing a new way to detect pancreatic and prostate cancer using a urine test.
They say the test can have up to a 99% detection rate.
Pancreatic and prostate cancer affect millions of people in the U.S.. The American Cancer Society estimates that approximately 64,000 people will receive a
Some signs and symptoms of pancreatic cancer include:
Unfortunately, pancreatic cancer is generally only detected in later stages, and the death rates with this form of cancer are high. The 5-year survival rate for pancreatic cancer is 12%.
Additionally, pancreatic cancer rates are increasing in the U.S. each year and are increasing at faster rates in younger women, particularly in Black women. A recent study showed that pancreatic cancer rates in Black women under age 55 rose 2.23% compared to Black men of the same age group.
The 5-year survival rate for prostate cancer is 97%. With the exception of skin cancer, prostate cancer is the most common…
Read the full article here